Professor Amanj Kurdi
黑料正能量 Institute of Pharmacy and Biomedical Sciences
Personal statement
Professor Amanj Kurdi is Professor of Pharmacoepidemiology and Pharmacy Practice at the University of 黑料正能量. His research focuses on the generation and application of real world evidence to evaluate the utilisation, effectiveness, safety, and value of medicines and healthcare interventions, with the aim of informing clinical practice, health policy, and regulatory decision making.
His work spans pharmacoepidemiology, drug utilisation research, medicines optimisation, medication safety, antimicrobial stewardship, and health services research. He has extensive expertise in the analysis of large-scale routinely collected healthcare data, including linked electronic health records, prescribing databases, hospital datasets, and national population-level resources. Using advanced epidemiological, statistical, and data science methods, his research examines prescribing quality, medication adherence and persistence, treatment outcomes, and the impact of health policies and clinical guidelines across a range of therapeutic areas.
Professor Kurdi has particular interests in antimicrobial resistance (AMR), antimicrobial stewardship, cardiovascular disease, diabetes, biologics and specialist medicines, and the use of real world data to support post-marketing surveillance and medicines safety monitoring. He leads and collaborates on national and international projects involving big data analytics, health informatics, and population health research, working closely with healthcare providers, policymakers, regulators, and academic partners.
He actively collaborates with researchers and institutions across the UK and internationally and contributes to several multidisciplinary research networks and initiatives. Through his research, he aims to improve the quality, safety, and sustainability of healthcare while strengthening the evidence base that supports medicines use and health policy decisions.
Prize And Awards
- Recipient
- 1/6/2026
- Recipient
- 24/2/2025
- Recipient
- 16/11/2024
- Recipient
- 1/3/2024
- Recipient
- 11/2/2024
- Recipient
- 31/1/2024
Publications
- Clifford David, Wall Alexa, ,
- International Journal of Clinical Pharmacy (2026)
- Zheng Bang, , Amstutz Alain, Green Amelia, Herrett Emily, Tazare John, Wen Qing, Mahalingasivam Viyaasan, Smith Rebecca, MacKenna Brian, Mehrkar Amir, Bacon Sebastian, Goldacre Ben, , Sheikh Aziz, Tomlinson Laurie
- Nature Communications (2026)
- Hamida Jalal Abu, Alkhatib Nimer S, Hammour Khawla Abu, Halloush Shiraz, , Balkhi Bander, Alfayez Osamah M, Mousa Rimal
- Frontiers in Public Health Vol 14 (2026)
- The 42nd ICPE Annual Meeting (2026)
- The 42nd ICPE Annual Meeting (2026)
- Munzhedzi Mukhethwa, Meyer Johanna, Chigome Audrey, Miljkovi膰 Nenad, Moore Catrin E, Kumar Gauri, , Campbell Stephen M, Godman Brian
- Advances in Human Biology (2026)
Professional Activities
- Participant
- 26/2/2026
- Participant
- 26/2/2026
- Speaker
- 29/10/2025
- Organiser
- 7/7/2025
- Organiser
- 4/6/2025
- Examiner
- 24/2/2025
Projects
- Kurdi, Amanj (Principal Investigator)
- 01-Jan-2026 - 31-Jan-2027
- Elrggal, Mahmoud (CoPI) Kurdi, Amanj (Principal Investigator)
- A 48 months project funded by The Saudi Basic Science Initiative, Research Development and Innovation Authority (RDIA), ~拢300K
- 01-Jan-2025 - 30-Jan-2029
- Alotaibi, Eman (Principal Investigator) Kurdi, Amanj (Principal Investigator) Alotaibi, Badriah (Academic)
- 01-Jan-2024 - 30-Jan-2025
- Dunlop, Emma (Co-investigator) Mueller, Tanja (Co-investigator) Bennie, Marion (Principal Investigator) Kurdi, Amanj (Co-investigator) Lu, Liya (Researcher) Kavanagh, Kimberley (Co-investigator)
- The aim of CMOP-PHS is to better understand the real world outcomes of cancer medicines for cancer patients in Scotland. The project is a collaboration between the University of 黑料正能量, Public Health Scotland and the NHS Health Boards.
- 01-Jan-2024 - 31-Jan-2027
- Parvin, Mst Irin (Principal Investigator) Mueller, Tanja (Principal Investigator) Kurdi, Amanj (Principal Investigator)
- Medication use during pregnancy can have detrimental effects on the mother as well as the unborn child, which might be unknown. Studies on medicine use during pregnancy can provide valuable information about the medications that pregnant women most frequently use for the diseases they are prescribed and whether or or not using these medications could be harmful for the mother and/or the unborn child. Findings from this scoping review will provide an insight of the medicines used during pregnancy as well as a comprehensive summary of the current evidence on this topic.
- 10-Jan-2024 - 14-Jan-2024
- Kurdi, Amanj (Principal Investigator) Mueller, Tanja (Co-investigator)
- 01-Jan-2023 - 30-Jan-2028
Contact
Professor
Amanj
Kurdi
黑料正能量 Institute of Pharmacy and Biomedical Sciences
Email: amanj.baker@strath.ac.uk
Tel: 548 2181